All Stories

  1. Early caffeine exposure: Transient and long-term consequences on brain excitability

    Article • Brain Research Bulletin, May 2014, Elsevier

    Jana Tchekalarova

  2. Treatment with melatonin after status epilepticus attenuates seizure activity and neuronal damage but does not prevent the disturbance in diurnal rhythms and behavioral alterations in spontaneously hypertensive rats in kainate model of temporal lobe ep...

    Article • Epilepsy & Behavior, February 2014, Elsevier

    Jana Tchekalarova

  3. Strain-dependent effects of long-term treatment with melatonin on kainic acid-induced status epilepticus, oxidative stress and the expression of heat shock proteins

    Article • Pharmacology Biochemistry and Behavior, October 2013, Elsevier

    Jana Tchekalarova

  4. Effects of caffeine on cortical epileptic afterdischarges in adult rats are modulated by postnatal treatment

    Article • Acta Neurologica Belgica, July 2013, Springer Science + Business Media

    Jana Tchekalarova

  5. Different effects of postnatal caffeine treatment on two pentylenetetrazole-induced seizure models persist into adulthood

    Article • Pharmacological Reports, July 2013, Springer Science + Business Media

    Jana Tchekalarova

  6. Prophylactic treatment with melatonin after status epilepticus: Effects on epileptogenesis, neuronal damage, and behavioral changes in a kainate model of temporal lobe epilepsy

    Article • Epilepsy & Behavior, April 2013, Elsevier

    Jana Tchekalarova

  7. Effect of long-term caffeine administration on depressive-like behavior in rats exposed to chronic unpredictable stress

    Article • Behavioural Pharmacology, August 2012, Wolters Kluwer Health

    Jana Tchekalarova

  8. P.2.013 Effects of melatonin on diurnal variations of spontaneous seizures and behavioural changes in kainate model of temporal lobe epilepsy

    Article • European Neuropsychopharmacology, March 2012, Elsevier

    Jana Tchekalarova

  9. P.1.d.005 Depressive -like behaviour of Wistar rats exposed to chronic unpredictable stress: effect of long-term caffeine administration

    Article • European Neuropsychopharmacology, September 2011, Elsevier

    Jana Tchekalarova

  10. P.1.d.013 Chronic unpredictable stress-induced antinociception: effect of long-term caffeine treatment

    Article • European Neuropsychopharmacology, September 2011, Elsevier

    Jana Tchekalarova

  11. Diurnal variations in depression-like behavior of Wistar and spontaneously hypertensive rats in the kainate model of temporal lobe epilepsy

    Article • Epilepsy & Behavior, February 2011, Elsevier

    Jana Tchekalarova

  12. The effects of chronic losartan pretreatment on restraint stress-induced changes in motor activity, nociception and pentylenetetrazol generalized seizures in rats

    Article • Folia Medica, January 2011, Pensoft Publishers

    Jana Tchekalarova

  13. Postnatal period of caffeine treatment and time of testing modulate the effect of acute caffeine on cortical epileptic afterdischarges in rats

    Article • Brain Research, October 2010, Elsevier

    Jana Tchekalarova

  14. Dose-dependent effects of caffeine on behavior and thermoregulation in a chronic unpredictable stress model of depression in rats

    Article • Behavioural Brain Research, June 2010, Elsevier

    Jana Tchekalarova

  15. Effects of early postnatal caffeine exposure on seizure susceptibility of rats are age- and model-dependent

    Article • Epilepsy Research, February 2010, Elsevier

    Jana Tchekalarova

  16. Postnatal caffeine treatment affects differently two pentylenetetrazol seizure models in rats

    Article • Seizure, September 2009, Elsevier

    Jana Tchekalarova

  17. P.2.d.001 Dose-dependent effects of caffeine in a chronic mild stress model of depression in ICR mice

    Article • European Neuropsychopharmacology, September 2009, Elsevier

    Jana Tchekalarova

  18. P.5.d.004 Behavioural changes in wistar and spontaneously hypertensive rats in kainate model of epilepsy

    Article • European Neuropsychopharmacology, September 2009, Elsevier

    Jana Tchekalarova

  19. Effects of postnatal caffeine exposure on seizure susceptibility in developing rats

    Article • Brain Research, May 2007, Elsevier

    Jana Tchekalarova

  20. Angiotensin II suppresses long-term depression in the lateral amygdala of mice via L-type calcium channels

    Article • Neuroscience Letters, March 2007, Elsevier

    Jana Tchekalarova

  21. Ang II and Ang III modulate PTZ seizure threshold in non-stressed and stressed mice: Possible involvement of noradrenergic mechanism

    Article • Neuropeptides, October 2006, Elsevier

    Jana Tchekalarova

  22. Biphasic effect of chronic postnatal caffeine treatment on cortical epileptic afterdischarges during ontogeny in rats

    Article • Brain Research, April 2006, Elsevier

    Jana Tchekalarova

  23. Effect of acute versus chronic theophylline administration on acute restraint stress-induced increase of pentylenetetrazol seizure threshold in mice

    Article • Brain Research Bulletin, February 2006, Elsevier

    Jana Tchekalarova

  24. Postnatal caffeine exposure: effects on motor skills and locomotor activity during ontogenesis

    Article • Behavioural Brain Research, May 2005, Elsevier

    Jana Tchekalarova

  25. Angiotensin peptides modulatory system: how is it implicated in the control of seizure susceptibility?

    Article • Life Sciences, January 2005, Elsevier

    Jana Tchekalarova

  26. Up-regulation of adenosine A1 receptor binding in pentylenetetrazol kindling in mice: effects of angiotensin IV

    Article • Brain Research, January 2005, Elsevier

    Jana Tchekalarova

  27. Down-regulation of dopamine D1 and D2 receptors in the basal ganglia of PTZ kindling model of epilepsy: effects of angiotensin IV

    Article • Brain Research, October 2004, Elsevier

    Jana Tchekalarova

  28. P4.002 Down-regulation of dopamine D1 andD2 receptors in the basal ganglia of the pentylenetetrazol kindling model of epilepsy: Effects of angiotensin IV

    Article • European Neuropsychopharmacology, October 2004, Elsevier

    Jana Tchekalarova

  29. The effects of sarmesin, an Angiotensin II analogue on seizure susceptibility, memory retention and nociception

    Article • Regulatory Peptides, March 2003, Elsevier

    Jana Tchekalarova

  30. Interaction of angiotensin II and III with adenosine A1 receptor-related drugs in passive avoidance conditioning in rats

    Article • Behavioural Brain Research, February 2002, Elsevier

    Jana Tchekalarova

  31. Effects of angiotensin III and angiotensin IV on pentylenetetrazol seizure susceptibility (threshold and kindling): interaction with adenosine A1 receptors

    Article • Brain Research Bulletin, September 2001, Elsevier

    Jana Tchekalarova

  32. Interaction between angiotensin IV and adenosine A1 receptor related drugs in passive avoidance conditioning in rats

    Article • Behavioural Brain Research, August 2001, Elsevier

    Jana Tchekalarova

  33. Long-term theophylline treatment changes the effects of angiotensin II and adenosinergic agents on the seizure threshold

    Article • Brain Research Bulletin, May 2000, Elsevier

    Jana Tchekalarova

  34. Adenosine-angiotensin II interactions in pentylenetetrazol seizure threshold in mice

    Article • Journal of Physiology-Paris, May 1999, Elsevier

    Jana Tchekalarova

  35. Further evidence for interaction between angiotensin II and dopamine receptors (experiments on apomorphine stereotypy)

    Article • Methods and Findings in Experimental and Clinical Pharmacology, January 1998, Prous Science

    Jana Tchekalarova

  36. Interaction of angiotensin II and adenosine receptors in pentylenetetrazol-induced kindling in mice

    Article • Brain Research, January 1998, Elsevier

    Jana Tchekalarova

  37. Interaction between adenosine and angiotensin II in pentylenetetrazol kindling seizures in mice

    Article • Biological Psychiatry, July 1997, Elsevier

    Jana Tchekalarova

  38. Influence of sarmesin on some dopamine-related types of behaviour

    Article • International Journal of Peptide Research and Therapeutics, September 1996, Springer Science + Business Media

    Jana Tchekalarova